CYTK
Cytokinetics Inc
NASDAQ · Biotechnology
$62.34
+2.10 (+3.49%)
Performance
1D
—
1W
-4.33%
1M
-3.56%
3M
-6.26%
6M
+69.03%
1Y
+47.69%
YTD
+0.99%
Open$61.31
Previous Close$60.24
Day High$62.74
Day Low$61.00
52W High$70.98
52W Low$29.31
Volume1.74M
Avg Volume1.61M
Market Cap7.62B
P/E Ratio—
EPS$-6.31
SectorBiotechnology
Volume Analysis
1.08x average volume
Technical Indicators
SMA 50
$63.64
Below
SMA 200
$48.96
Above
RSI (14)
49.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+28.0% upside
Current
$62.34
$62.34
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 20.17M | 31.51M | 700.83M |
| Net Income | -643,675,972 | -904,886,558 | 151.73M |
| Profit Margin | -3,191.1% | -3,031.6% | 21.7% |
| EBITDA | -596,493,934 | -885,144,075 | 326.98M |
| Free Cash Flow | — | — | 119.78M |
| Rev Growth | -36.0% | -36.0% | +24.1% |
| Debt/Equity | 0.59 | 0.59 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |